| Breakdown | TTM | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 103.97B | 95.57B | 88.42B | 102.30B | 101.20B | 86.67B |
| Gross Profit | 21.58B | 21.25B | 21.07B | 22.69B | 21.89B | 20.14B |
| EBITDA | 8.27B | 9.59B | 8.89B | 7.66B | 12.02B | 9.79B |
| Net Income | 5.21B | 4.59B | 3.39B | 2.44B | 5.56B | 3.25B |
Balance Sheet | ||||||
| Total Assets | 87.48B | 79.75B | 82.13B | 89.61B | 92.73B | 123.42B |
| Cash, Cash Equivalents and Short-Term Investments | 9.57B | 3.63B | 7.37B | 8.61B | 9.48B | 9.51B |
| Total Debt | 31.24B | 24.57B | 25.99B | 29.59B | 26.95B | 41.45B |
| Total Liabilities | 90.10B | 81.13B | 84.26B | 92.64B | 94.31B | 115.39B |
| Stockholders Equity | -2.62B | -1.48B | -2.23B | -3.12B | -1.69B | 2.95B |
Cash Flow | ||||||
| Free Cash Flow | 4.45B | 1.87B | 5.92B | 562.00M | 7.51B | 9.32B |
| Operating Cash Flow | 7.10B | 4.52B | 8.68B | 3.56B | 10.31B | 11.41B |
| Investing Cash Flow | -2.04B | -2.21B | -2.78B | -3.02B | 1.31B | -460.00M |
| Financing Cash Flow | -762.00M | -5.82B | -7.09B | -1.63B | -16.61B | -5.95B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | $91.73B | 28.15 | 41.27% | 0.18% | -16.35% | 316.56% | |
70 Outperform | $19.78B | 17.50 | 125.35% | 1.89% | 2.64% | 4.12% | |
70 Outperform | $86.36B | 46.07 | ― | 1.02% | 31.56% | 106.00% | |
65 Neutral | $79.38B | 15.89 | ― | 1.45% | 10.81% | 31.67% | |
64 Neutral | $22.36B | 178.78 | 9.27% | ― | 13.18% | -0.92% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
61 Neutral | $16.71B | 6.91 | ― | 5.09% | 4.09% | -5.77% |